Newton Biocapital
Brussels, Belgium · Pre-seed → Series B
Their stated focus (public profile)
Newton Biocapital is a life sciences venture capital fund investing in early-stage companies in Europe and Japan focused on innovative solutions for chronic health conditions, including oncology, autoimmune, neurological, metabolic, and genetic diseases. The fund takes an active, hands-on approach as lead investor and board member, supporting companies from preclinical through clinical stages. It leverages its dual presence in Belgium and Japan to build international investor syndicates and facilitate access to global pharmaceutical networks for optimal exits.
Stages: Pre-seed → Series B
Sectors: Life sciences, Medtech, Healthtech
On file: 14 partners on record · 12 companies on record
Website: newtonbiocapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.